Indeed, the administration of aromatase inhibitors suggests that brain-derived E2 is anti-inflammatory and neuroprotective in both penetrating and traumatic brain injuries [8,29,47,48], and global aromatase knockout mice and aromatase inhibitor studies following an FCI have shown a similar protective beneficial role for this brain-derived E2 [33]. Here, CYP19A1 is linked to brain injury.